Atossa Therapeutics
ATOS
#9469
Rank
A$0.11 B
Marketcap
A$0.91
Share price
6.02%
Change (1 day)
-34.98%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$0.59 M-68.3%
2024A$1.86 M265.91%
2023A$0.5 M-93.57%
2022A$7.92 M-92.88%
2021A$0.11 B731.9%
2020A$13.37 M-10.09%
2019A$14.87 M138.47%
2018A$6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
A$32.98 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.02 MA$32.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$10.73 MA$37.61 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
N/AA$0.22 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$0.05 MA$13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$2.45 MA$5.15 M๐Ÿ‡บ๐Ÿ‡ธ USA